Notice: This company has been marked as potentially delisted and may not be actively trading. Range Cancer Therapeutics ETF (CNCR) Holdings Add Compare Share Share Holdings Stock AnalysisHeadlinesHoldingsRatingsShort InterestTrends Top 50 CNCR HoldingsRankCompanyCurrent PriceWeightShares Held1RXRXRecursion Pharmaceuticals$6.88+5.4%3.35%50,7612DNAGinkgo Bioworks$11.55+6.6%2.83%26,8803CMPXCompass Therapeutics$2.61+0.4%2.53%97,9314VORVor Biopharma$1.36+2.3%2.33%165,8055EXELExelixis$36.43+0.6%2.30%6,0966BPMCBlueprint Medicines$111.96+1.7%2.08%1,9407BMYBristol-Myers Squibb$57.01+1.3%1.95%3,3508ZYMEZymeworks$14.29+3.0%1.93%13,3869PGENPrecigen$1.18+6.3%1.92%167,49610GLUEMonte Rosa Therapeutics$5.69+0.5%1.77%29,798 Get the Latest News and Ratings for CNCR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Range Cancer Therapeutics ETF and its competitors with MarketBeat's FREE daily newsletter. 11SWTXSpringWorks Therapeutics$36.35+5.0%1.73%4,70912REPLReplimune Group$11.85+16.9%1.71%16,01013ELVNEnliven Therapeutics$22.00+2.5%1.70%7,48314GNLXGenelux$2.89+17.5%1.69%65,93015XNCRXencor$20.45+6.3%1.64%7,91816SDGRSchrödinger$21.33+12.3%1.63%8,43217BNTXBioNTech$117.25+4.8%1.58%1,35618KPTIKaryopharm Therapeutics$0.69+4.1%1.58%218,79119DAWNDay One Biopharmaceuticals$12.24-2.4%1.57%12,28620RVMDRevolution Medicines$40.16-0.3%1.55%3,76021MGNXMacroGenics$3.001.53%48,82322IMCRImmunocore$30.00+3.4%1.52%5,07523IBRXImmunityBio$3.22+9.5%1.51%47,98424ACLXArcellx$66.57+0.1%1.50%2,17525MRKMerck & Co., Inc.$96.18-1.8%1.48%1,42026RCUSArcus Biosciences$14.11+0.6%1.44%9,90927KYMRKymera Therapeutics$43.70+7.6%1.44%3,45428NUVBNuvation Bio$2.60+3.4%1.43%54,54829JANXJanux Therapeutics$40.91+0.5%1.41%3,35730HCMHUTCHMED$14.21+0.1%1.39%10,13131TYRATyra Biosciences$15.91-1.7%1.39%8,31132GMABGenmab A/S$21.80+4.8%1.38%6,30033MRUSMerus$39.74+0.7%1.37%3,33634INBXInhibrx$14.19+5.2%1.34%9,60835AURAAura Biosciences$7.93+2.1%1.33%16,79736IPHAInnate Pharma$1.77+4.4%1.33%77,35037NRIXNurix Therapeutics$19.60+2.4%1.32%6,58338CRBUCaribou Biosciences$1.52-0.7%1.31%82,49439APLMApollomics$9.52-0.4%1.24%12,59240SNDXSyndax Pharmaceuticals$13.67+4.5%1.23%9,201Did You See Trump’s Manhattan Project Bombshell? (Ad)This secret document contains stunning details about Donald Trump’s very first order of business… the minute he steps back into the White House. Because if what’s in this leaked document is even half true (and trust me, it comes from a very, very credible source)... Trump’s first Executive Order would easily be the boldest, most mind-blowing and daring American initiative ANY U.S. President has launched in over 80 years. Click here and see for yourself.41ARVNArvinas$18.57+2.9%1.21%6,65942IMRXImmuneering$2.12+5.0%1.18%58,34943ACRVAcrivon Therapeutics$5.65-2.2%1.17%20,34844NUVLNuvalent$78.28+3.2%1.17%1,49345ALLOAllogene Therapeutics$1.84+1.1%1.15%60,67546GERNGeron$2.96+2.4%1.15%38,32147ERASErasca$1.90+2.7%1.14%59,38448ZNTLZentalis Pharmaceuticals$2.25+0.4%1.12%45,50649ITOSiTeos Therapeutics$8.06+0.8%1.11%13,84050RAPTRAPT Therapeutics$1.201.09%89,076 Geographic ExposureUnited States95.2%Netherlands2.1%Currency ExposureUSD100.0%Sector ExposureHealth Care30.4%Industry ExposureBiotechnology30.4%SubIndustry ExposureBiotechnology23.4%Pharmaceuticals2.5%Coupon Exposure4-60.8%Maturity Exposure5-100.8% Related Companies and Tools Related Companies JPMorgan Healthcare Leaders ETF Portfolio First Trust Nasdaq Pharmaceuticals ETF Portfolio Horizon Kinetics Medical ETF Portfolio ProShares UltraShort Nasdaq Biotechnology Portfolio Invesco Nasdaq Biotechnology ETF Portfolio F/m Emerald Life Sciences Innovation ETF Portfolio ProShares Ultra Nasdaq Biotechnology Portfolio Invesco Dorsey Wright Healthcare Momentum ETF Portfolio Invesco S&P SmallCap Health Care ETF Portfolio VanEck Biotech ETF Portfolio This page (NASDAQ:CNCR) was last updated on 1/22/2025 by MarketBeat.com Staff From Our PartnersBill Gates’ is about to mint millionaires (again) with Stargate.This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredDid You See Trump’s Manhattan Project Bombshell?This secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredTrump currency shock imminentTrump's Quiet $1.9 Trillion Move Against the Fed A small army of Americans, with Trump's support, has launc...Stansberry Research | SponsoredJanuary 29th - the next big trading catalyst to watch Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | SponsoredElon’s #1 AI Stock” SET TO SOARForget ChatGPT! Because Elon Musk's AI promises to be 100x more powerful.Behind the Markets | SponsoredI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredNvidia’s Bold Move: Tackling Tech’s $1 Trillion CrisisTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Range Cancer Therapeutics ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Range Cancer Therapeutics ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CNCR Stock Alerts